OpenAI is reportedly in discussions with the U.S. Food and Drug Administration (FDA) about using AI to help evaluate pharmaceuticals, according to a new report from Wired.<br /> The article OpenAI plans "cderGPT" for the US Food and Drug Administration (FDA) appeared first on THE DECODER. [...]
Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two co [...]
Newly restored pages on the websites of government agencies like the Food and Drug Administration (FDA) and Substance Abuse and Mental Health Services Administration (SAMHSA) now include a disclaimer [...]
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]
OpenAI on Thursday launched GPT-5.3-Codex-Spark, a stripped-down coding model engineered for near-instantaneous response times, marking the company's first significant inference partnership outsi [...]
Earlier today, OpenAI launched GPT-5.6-Cyber, a specialized model designed to perform advanced vulnerability research and exploit development for approved defenders — including categories of work th [...]
OpenAI on Monday launched a set of interactive visual tools inside ChatGPT that let users manipulate mathematical and scientific formulas in real time — a genuinely impressive education feature that [...]
OpenAI on Wednesday launched GPT-Live, a pair of new voice models that fundamentally redesign how people talk to ChatGPT — replacing the company's existing Advanced Voice Mode with an architect [...]